GlassScriptPhysician profile
Dayana Rubio
NPI 1629276241
$6,020.07
in general payments reported to CMS, 2019-2025
43 companies · $830 in 2025
The $830 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,702 · 2022: $1,481 · 2023: $1,302 · 2024: $706 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,818 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,818.10 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,174.12 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $847.97 | 2021-2025 | |
| Lilly USA, LLC | $677.52 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $443.37 | 2021-2025 | Jardiance, Synjardy, Glyxambi |
| Pfizer INC. | $397.68 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $268.23 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $263.46 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $207.91 | 2021-2024 | |
| Nestle Healthcare Nutrition INC. | $196.65 | 2021-2022 | |
| Amgen INC. | $152.87 | 2023-2024 | Repatha, Otezla, Krystexxa |
| Biohaven Pharmaceutical Holding Company LTD. | $147.35 | 2022 | |
| Glaxosmithkline, LLC. | $140.88 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $111.10 | 2021-2023 | |
| Boston Scientific Corporation | $86.92 | 2023 | Wavewriter Alpha Prime 16 |
| Phadia US INC. | $82.72 | 2021-2025 | Immunocap |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayana Rubio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.